These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 19818758

  • 21. Release of both CCR4-active and CXCR3-active chemokines during human allergic pulmonary late-phase reactions.
    Bochner BS, Hudson SA, Xiao HQ, Liu MC.
    J Allergy Clin Immunol; 2003 Nov; 112(5):930-4. PubMed ID: 14610482
    [Abstract] [Full Text] [Related]

  • 22. Percutaneous application of peptidoglycan from Staphylococcus aureus induces infiltration of CCR4+ cells into mouse skin.
    Matsui K, Nishikawa A.
    J Investig Allergol Clin Immunol; 2011 Nov; 21(5):354-62. PubMed ID: 21905498
    [Abstract] [Full Text] [Related]

  • 23. Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis.
    Shimada Y, Takehara K, Sato S.
    J Dermatol Sci; 2004 May; 34(3):201-8. PubMed ID: 15113590
    [Abstract] [Full Text] [Related]

  • 24. CCL17 and CCL22 attenuate CCL5-induced mast cell migration.
    Juremalm M, Olsson N, Nilsson G.
    Clin Exp Allergy; 2005 Jun; 35(6):708-12. PubMed ID: 15969658
    [Abstract] [Full Text] [Related]

  • 25. The C-C chemokine receptors CCR4 and CCR8 identify airway T cells of allergen-challenged atopic asthmatics.
    Panina-Bordignon P, Papi A, Mariani M, Di Lucia P, Casoni G, Bellettato C, Buonsanti C, Miotto D, Mapp C, Villa A, Arrigoni G, Fabbri LM, Sinigaglia F.
    J Clin Invest; 2001 Jun; 107(11):1357-64. PubMed ID: 11390417
    [Abstract] [Full Text] [Related]

  • 26. Blockade of CCR4 in a humanized model of asthma reveals a critical role for DC-derived CCL17 and CCL22 in attracting Th2 cells and inducing airway inflammation.
    Perros F, Hoogsteden HC, Coyle AJ, Lambrecht BN, Hammad H.
    Allergy; 2009 Jul; 64(7):995-1002. PubMed ID: 19630858
    [Abstract] [Full Text] [Related]

  • 27. CC chemokine receptor 4 ligand production by bronchoalveolar lavage fluid cells in cigarette-smoke-associated acute eosinophilic pneumonia.
    Nureki S, Miyazaki E, Ando M, Kumamoto T, Tsuda T.
    Clin Immunol; 2005 Jul; 116(1):83-93. PubMed ID: 15925835
    [Abstract] [Full Text] [Related]

  • 28. Internalization of the chemokine receptor CCR4 can be evoked by orthosteric and allosteric receptor antagonists.
    Ajram L, Begg M, Slack R, Cryan J, Hall D, Hodgson S, Ford A, Barnes A, Swieboda D, Mousnier A, Solari R.
    Eur J Pharmacol; 2014 Apr 15; 729(100):75-85. PubMed ID: 24534492
    [Abstract] [Full Text] [Related]

  • 29. Induction of surface CCR4 and its functionality in mouse Th2 cells is regulated differently during Th2 development.
    Morimoto Y, Bian Y, Gao P, Yashiro-Ohtani Y, Zhou XY, Ono S, Nakahara H, Kogo M, Hamaoka T, Fujiwara H.
    J Leukoc Biol; 2005 Sep 15; 78(3):753-61. PubMed ID: 16126843
    [Abstract] [Full Text] [Related]

  • 30. Up-regulation of CCL17, CCL22 and CCR4 in drug-induced maculopapular exanthema.
    Tapia B, Morel E, Martín-Díaz MA, Díaz R, Alves-Ferreira J, Rubio P, Padial A, Bellón T.
    Clin Exp Allergy; 2007 May 15; 37(5):704-13. PubMed ID: 17456218
    [Abstract] [Full Text] [Related]

  • 31. Dominance of CCL22 over CCL17 in induction of chemokine receptor CCR4 desensitization and internalization on human Th2 cells.
    Mariani M, Lang R, Binda E, Panina-Bordignon P, D'Ambrosio D.
    Eur J Immunol; 2004 Jan 15; 34(1):231-40. PubMed ID: 14971049
    [Abstract] [Full Text] [Related]

  • 32. Regulation of macrophage-derived chemokine (MDC, CCL22) production.
    Yamashita U, Kuroda E.
    Crit Rev Immunol; 2002 Jan 15; 22(2):105-14. PubMed ID: 12433129
    [Abstract] [Full Text] [Related]

  • 33. Production of a monoclonal antibody to canine thymus and activation-regulated chemokine (TARC) and detection of TARC in lesional skin from dogs with atopic dermatitis.
    Maeda S, Tsukui T, Saze K, Masuda K, Ohno K, Tsujimoto H, Iwabuchi S.
    Vet Immunol Immunopathol; 2005 Jan 10; 103(1-2):83-92. PubMed ID: 15626464
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
    Hüser N, Tertilt C, Gerauer K, Maier S, Traeger T, Assfalg V, Reiter R, Heidecke CD, Pfeffer K.
    Eur J Immunol; 2005 Jan 10; 35(1):128-38. PubMed ID: 15593118
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. CC chemokine ligand 17 in periodontal diseases: expression in diseased tissues and production by human gingival fibroblasts.
    Hosokawa Y, Hosokawa I, Ozaki K, Nakae H, Matsuo T.
    J Periodontal Res; 2008 Aug 10; 43(4):471-7. PubMed ID: 18557811
    [Abstract] [Full Text] [Related]

  • 38. CCL22-induced responses are powerfully enhanced by synergy inducing chemokines via CCR4: evidence for the involvement of first beta-strand of chemokine.
    Sebastiani S, Danelon G, Gerber B, Uguccioni M.
    Eur J Immunol; 2005 Mar 10; 35(3):746-56. PubMed ID: 15714581
    [Abstract] [Full Text] [Related]

  • 39. Serum concentrations of CCR4 ligands in relation to clinical severity of atopic dermatitis in Egyptian children.
    Mostafa GA, Tomoum HY, Salem SA, Abd El-Aziz MM, Abou El-Maged DI, El-Sayed El-Far I.
    Pediatr Allergy Immunol; 2008 Dec 10; 19(8):756-62. PubMed ID: 18435706
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M, Hermans B, Goossens J, Moechars D, Gilissen RA, Doyon J, Boeckx S, Coesemans E, Van Lommen G, Van Wauwe JP.
    J Pharmacol Exp Ther; 2008 Oct 10; 327(1):1-9. PubMed ID: 18599682
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.